Delta-like 3 is silenced by methylation and induces apoptosisin human hepatocellular carcinoma

International Journal of Oncology

Volumn 42, Issue 3, 2013, Pages 817-822

  Maemura, Kentaro ^a   Yoshikawa, Hirohide ^b   Yokoyama, Kazutake ^a   Ueno, Teruo ^a   Kurose, Hitomi ^a   Uchiyama, Kazuhisa ^a   Otsuki, Yoshinori ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b Sassa General Hospital   (Japan)

Author keywords

Apoptosis; Delta like 3; Hepatocellular carcinoma; Methylation

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; COMPLEMENTARY DNA; DLL3 PROTEIN; LIPOCORTIN 5; MEMBRANE PROTEIN; SINGLE STRANDED DNA; TRICHOSTATIN A; UNCLASSIFIED DRUG; DLL3 PROTEIN, HUMAN; MESSENGER RNA; NOTCH1 PROTEIN, HUMAN; NOTCH1 RECEPTOR; SIGNAL PEPTIDE;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL ASSAY; COLONY FORMATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MOLECULAR CLONING; NICK END LABELING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CELL PROLIFERATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; METABOLISM; TUMOR CELL LINE;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CPG ISLANDS; DNA METHYLATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MEMBRANE PROTEINS; PROMOTER REGIONS, GENETIC; RECEPTOR, NOTCH1; RNA, MESSENGER;

MLCS; MLOWN;

EID: 84873650297     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1778     Document Type: Article

References (31)

1. Herath NI, Leggett BA and MacDonald GA: Review of genetic and epigenetic alterations in hepatocarcinogenesis. J Gastroenterol Hepatol 21: 15-21, 2006.
2. Yang B, Guo M, Herman JG and Clark DP: Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 163: 1101-1107, 2003. (Pubitemid 37040145)
3. Zhu JD: DNA methylation and hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 13: 265-273, 2006.
4. Lee S, Lee HJ, Kim JH, Lee HS, Jang JJ and Kang GH: Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am J Pathol 163: 1371-1378, 2003. (Pubitemid 37175085)
5. Nagai H, Ponglikitmongkol M, Mita E, Ohmachi Y, Yoshikawa H, Saeki R, Yumoto Y, Nakanishi T and Matsubara K: Aberration of genomic DNA in association with human hepatocellular carcinomas detected by 2-dimensional gel analysis. Cancer Res 54: 1545-1550, 1994. (Pubitemid 24106420)
6. Yoshikawa H, Monte DL, Nagai H, Wands JR, Matsubara K and Fujiyama A: Chromosomal assignment of human genomic NotI restriction fragments in a two-dimentional electrophoresis profile. Genomics 31: 28-35, 1996. (Pubitemid 26044749)
7. Yoshikawa H, Nagai H, Oh KS, Tamai S, Fujiyama A, Nakanishi T, Kajiyama G and Matsubara K: Chromosomal assignment of aberrant NotI restriction DNA fragments in primary hepatocellular carcinoma. Gene 197: 129-135, 1997. (Pubitemid 27399884)
8. Yoshikawa H, Matsubara K, Qian GS, Jackson P, Groopman JD, Manning JE, Harris C and Herman JG: SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet 28: 29-35, 2001. (Pubitemid 32405812)
9. Niwa Y, Kanda H, Shikauchi Y, Saiura A, Matsubara K, Kitagawa T, Yamamoto J, Kubo T and Yoshikawa H: Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STS and FAK signaling in human hepatocellular carcinoma. Oncogene 24: 6406-6417, 2005. (Pubitemid 41486474)
10. Kubo T, Yamamoto J, Shikauchi Y, Niwa Y, Matsubara K and Yoshikawa H: Apoptotic speck protein-like, a highly homologous protein to apoptotic speck protein in the pyrin domain, is silenced by DNA methylation and induces apoptosis in human hepatocellular carcinoma. Cancer Res 64: 5172-5177, 2004. (Pubitemid 39006535)
11. D'Souza B, Miyamoto A and Weinmaster G: The many facets of Notch ligands. Oncogene 27: 5148-5167, 2008.
12. Bray SJ: Notch signaling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 7: 678-689, 2006. (Pubitemid 44268213)
13. Fiuza UM and Arias AM: Cell and molecular biology of Notch. J Endocrinol 194: 459-474, 2007. (Pubitemid 47471215)
14. Dunwoodie SL, Henrique D, Harrison SM and Beddington RSP: Mouse Dll3: a novel divergent Delta gene which may complement the function of other Delta homologues during early pattern formation in the mouse. Development 124: 3065-3076, 1997. (Pubitemid 27387084)
15. Ladi E, Nichols JT, Ge W, Miyamoto A, Yao C, Yang LT, Boulter J, Sun YE, Kintner C and Weinmaster G: The divergent DSL ligand Dll3 does not activate Notch signaling but cell autonomously attenuates signaling induced by other DSL ligands. J Cell Biol 170: 983-992, 2005. (Pubitemid 41306297)
16. Geffers I, Serth K, Chapman G, Jaekel R, Schuster-Gossler K, Cardes R, Sparrow DB, Kremmer E, Dunwoodie S, Klein T and Gossler A: Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo. J Cell Biol 30: 465-476, 2007. (Pubitemid 47196154)
17. Conlon RA, Reaume AG and Rossant J: Notch1 is required for the coordinate segmentation of somites. Development 121: 1633-1645, 1995.
18. Kusumi K, Sun ES, Kerrebrock AW, Bronson RT, Chi DC and Bulotsky MS: The mouse pudgy mutation disrupts Delta homologue Dll3 and initiation of early somite boundaries. Nat Genet 19: 274-278, 1998. (Pubitemid 28309342)
19. Dunwoodie SL, Clements M, Sparrow DB, Sa X, Conlon RA and Beddington RS: Axial skeletal defects caused by mutation in the spondylocostal dysplasia/pudgy gene Dll3 are associated with disruption of the segmentation clock within the presomitic mesoderm. Development 129: 1795-1806, 2002. (Pubitemid 34874195)
20. Bulman MP, Kusumi K, Frayling TM, McKeown C, Garrette C, Lander ES, Krumlauf R, Hattersley AT, Ellard S and Turnpenny PD: Mutations in the human delta homologues, DLL3, cause axial skeletal defects in spondylocostal dysostosis. Nat Genet 24: 438-441, 2000. (Pubitemid 30187449)
21. Sparrow DB, Clements M, Withington SL, Scott AN, Novotny J, Sillence D, Kusumi K, Beddington RS and Dunwoodie SL: Diverse requirements for N signaling in mammals. Int J Dev Biol 46: 365-374, 2002.
22. Turnpenny PD, Whittock N, Duncan J, Dunwoodie S, Kusumi K and Ellard S: Novel mutations in DLL3, a somitogenesis gene encoding a ligand for the N signaling pathway, cause a consistent pattern of abnormal vertebral segmentation in spondylocostal dysostosis. J Med Genet 40: 333-339, 2003. (Pubitemid 36613469)
23. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996. (Pubitemid 26296693)
24. Lunn RM, Zhang YJ, Wang LY, Chen CJ, Lee PH, Lee CS, Tsai WY and Santella RM: p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res 57: 3471-3477, 1997. (Pubitemid 27355494)
25. De la Costa A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A and Perret C: Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 95: 8847-8851, 1998. (Pubitemid 28350577)
26. Matsuda Y, Ichida T, Matsuzawa J, Sugimura K and Asakura H: p16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma. Gastroenterology 116: 394-400, 1999. (Pubitemid 29055363)
27. Schagdarsurengin U, Wikens L, Steinemann D, Flemming P, Kreipe HH, Pfeifer GP, Schlegelberger B and Dammann R: Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma. Oncogene 22: 1866-1871, 2003. (Pubitemid 36513145)
28. Tchou JC, Lin X, Freije D, Isaacs WB, Brooks JD, Rashid A, De Marzo AM, Kanai Y, Hirohashi S and Nelson WG: GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas. Int J Oncol 16: 663-676, 2000.
29. Liu J, Lian Z, Han S, Waye MMY, Wang H, Wu MC, Wu K, Ding J, Arbuthnot P, Kew M, Fan D and Feitelson MA: Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellular carcinoma. Oncogene 25: 1008-1017, 2006. (Pubitemid 43277009)
30. Parks AL, Stout JR, Shepard SB, Klueg KM, Dos Santos AA, Parody TR, Voskova M and Muskavitch AT: Structure-function analysis of delta trafficking, receptor binding and signaling in Drosophila. Genetics 174: 1947-1961, 2006. (Pubitemid 46011585)
31. Shimizu K, Chiba S, Kumano K, Hosoya N, Takahashi T, Kanda Y, HamadaY, Yazaki Y and Hirai H: Mouse Jagged1 physically interacts with Notch2 and other Notch receptors. Assessment by quantitative methods. J Biol Chem 274: 32961-32969, 1999. (Pubitemid 129535335)